By Dr. Ted Tyberg, M.D.
The Food and Drug Administration announced that they approved the new Medtronic artificial pancreas system for type 1 diabetics. Presently, diabetics must test their blood sugar by sticking themselves several times a day and telling their pump how much insulin to deliver. A continuous glucose sensor that a patient implants weekly has been available for several years, but has not communicated with the pump.
The new system frees patients from having to constantly monitor and intervene, as well as calculate how much insulin to take. It is like a dream come true for over 1 million diabetics in the US alone.
Medtronic will begin marketing the system this year. Would this help you in your daily insulin management?Leave a reply →